A detailed history of First Horizon Advisors, Inc. transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 89 shares of RVMD stock, worth $3,110. This represents 0.0% of its overall portfolio holdings.

Number of Shares
89
Previous 58 53.45%
Holding current value
$3,110
Previous $2,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 05, 2025

BUY
$31.13 - $41.98 $965 - $1,301
31 Added 53.45%
89 $3,000
Q1 2025

Apr 28, 2025

BUY
$35.36 - $44.42 $1,520 - $1,910
43 Added 286.67%
58 $2,000
Q3 2024

Nov 08, 2024

BUY
$36.92 - $47.94 $553 - $719
15 New
15 $0

Others Institutions Holding RVMD

About Revolution Medicines, Inc.


  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $3.07B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track First Horizon Advisors, Inc. Portfolio

Follow First Horizon Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Advisors, Inc. with notifications on news.